Picture of TOWA PHARMACEUTICAL logo

4553 — TOWA PHARMACEUTICAL News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Towa Pharmaceutical -2023/24 parent results

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          149.22          124.00                                
               (+20.3 pct)     (+0.6 pct)                              
  Operating       19.96            9.31                                
              (+114.5 pct)     (-50.3 pct)                             
  Recurring       27.23            8.54                                
              (+218.8 pct)     (-62.0 pct)                             
  Net             19.60            6.33                                
              (+209.6 pct)     (-61.2 pct)                             
  EPS          398.21 yen      128.60 yen                              
  Ann Div       60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div       30.00 yen       30.00 yen      30.00 yen               
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T

Recent news on TOWA PHARMACEUTICAL

See all news